{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:59:18Z","timestamp":1793476758176,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.hrthm.2020.04.036","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T21:31:09Z","timestamp":1588541469000},"page":"1566-1574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study"],"prefix":"10.1016","volume":"17","author":[{"given":"Mikhael F.","family":"El-Chami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Herre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Sadhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Niebauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Kutalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2020.04.036_bib1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/CIRCEP.114.001455","article-title":"Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease","volume":"7","author":"Hess","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.04.036_bib2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/ndt\/gfu274","article-title":"Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study","volume":"30","author":"Pun","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.hrthm.2020.04.036_bib3","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/jce.12705","article-title":"Outcome of subcutaneous implantable cardioverter defibrillator implantation in patients with end-stage renal disease on dialysis","volume":"26","author":"El-Chami","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.04.036_bib4","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","article-title":"US Renal Data System 2018 Annual Data Report: epidemiology of kidney disease in the United States","volume":"73","author":"Saran","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.hrthm.2020.04.036_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10840-015-0093-2","article-title":"Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis","volume":"45","author":"Koman","year":"2016","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.04.036_bib6","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.ajkd.2011.03.026","article-title":"Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States","volume":"58","author":"Charytan","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.hrthm.2020.04.036_bib7","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.hrthm.2009.08.006","article-title":"Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation","volume":"6","author":"Aggarwal","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2020.04.036_bib8","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1540-8159.2007.00818.x","article-title":"Effect of end-stage renal failure and hemodialysis on mortality rates in implantable cardioverter-defibrillator recipients","volume":"30","author":"Hreybe","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.04.036_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/j.ajkd.2013.11.018","article-title":"Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis patients","volume":"64","author":"Hickson","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.hrthm.2020.04.036_bib10","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","article-title":"Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator","volume":"128","author":"Weiss","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.04.036_bib11","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/eurheartj\/ehu112","article-title":"Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry","volume":"35","author":"Lambiase","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2020.04.036_bib12","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.04.036_bib13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5527\/wjn.v5.i6.489","article-title":"Bacteremia in hemodialysis patients","volume":"5","author":"Suzuki","year":"2016","journal-title":"World J Nephrol"},{"key":"10.1016\/j.hrthm.2020.04.036_bib14","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.hrthm.2017.05.016","article-title":"Subcutaneous implantable cardioverter-defibrillator post-approval study: clinical characteristics and perioperative results","volume":"14","author":"Gold","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2020.04.036_bib15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ahj.2015.02.025","article-title":"Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: findings from the National Cardiovascular Data Registry (NCDR)","volume":"170","author":"Russo","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2020.04.036_bib16","doi-asserted-by":"crossref","first-page":"150285","DOI":"10.4061\/2010\/150285","article-title":"Impact of moderate to severe renal impairment on mortality and appropriate shocks in patients with implantable cardioverter defibrillators","volume":"2010","author":"Alla","year":"2010","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.hrthm.2020.04.036_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10840-018-0343-1","article-title":"Dialytic interval and the timing of electrocardiographic screening for subcutaneous cardioverter-defibrillator placement in chronic hemodialysis patients","volume":"52","author":"You","year":"2018","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.04.036_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.joa.2015.04.007","article-title":"A case of inappropriate implantable cardioverter defibrillator therapy induced by T-wave oversensing due to hyperkalemia","volume":"31","author":"Aoki","year":"2015","journal-title":"J Arrhythm"},{"key":"10.1016\/j.hrthm.2020.04.036_bib19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/europace\/eut383","article-title":"The effect of hyperkalaemia on cardiac rhythm devices","volume":"16","author":"Barold","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2020.04.036_bib20","first-page":"164","article-title":"Transient hyperkalemia-induced T-wave oversensing as a cause of inappropriate ICD discharges","volume":"8","author":"Bortnik","year":"2013","journal-title":"J Cardiol Cases"},{"key":"10.1016\/j.hrthm.2020.04.036_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ccep.2015.10.024","article-title":"Inappropriate implantable cardioverter-defibrillator shock from QRS double counting in the setting of hyperkalemia","volume":"8","author":"Dadlani","year":"2016","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.hrthm.2020.04.036_bib22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.hrcr.2015.04.007","article-title":"Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation","volume":"1","author":"Kiamanesh","year":"2015","journal-title":"HeartRhythm Case Rep"},{"key":"10.1016\/j.hrthm.2020.04.036_bib23","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.hrthm.2018.05.011","article-title":"Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator","volume":"15","author":"Theuns","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2020.04.036_bib24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.joa.2017.05.002","article-title":"Long-term survival of implantable cardioverter defibrillator recipients with end-stage renal disease","volume":"33","author":"El-Chami","year":"2017","journal-title":"J Arrhythm"},{"key":"10.1016\/j.hrthm.2020.04.036_bib25","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1053\/j.ajkd.2016.12.006","article-title":"Sudden cardiac death among hemodialysis patients","volume":"69","author":"Makar","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.hrthm.2020.04.036_bib26","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2020.04.036_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2020.04.036_bib28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.amjcard.2006.03.025","article-title":"Multicenter Automatic Defibrillator Implantation Trial II Investigators. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction","volume":"98","author":"Goldenberg","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2020.04.036_bib29","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1053\/j.ajkd.2007.02.272","article-title":"Increased complication rates of cardiac rhythm management devices in ESRD patients","volume":"49","author":"Dasgupta","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.hrthm.2020.04.036_bib30","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/CIRCULATIONAHA.119.039818","article-title":"Prophylactic use of implantable cardioverter-defibrillators in the prevention of sudden cardiac death in dialysis patients","volume":"139","author":"Jukema","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2020.04.036_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005706","article-title":"Transvenous lead extraction in chronic kidney disease and dialysis patients with infected cardiac devices","volume":"11","author":"Barakat","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.04.036_bib32","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jacc.2014.12.049","article-title":"Bradycardia and asystole is the predominant mechanism of sudden cardiac death in patients with chronic kidney disease","volume":"65","author":"Wong","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2020.04.036_bib33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jacep.2017.08.002","article-title":"Cardiac rhythm disturbances in hemodialysis patients: early detection using an implantable loop recorder and correlation with biological and dialysis parameters","volume":"4","author":"Sacher","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2020.04.036_bib34","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/jamacardio.2016.2782","article-title":"Trends and in-hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States","volume":"1","author":"Friedman","year":"2016","journal-title":"JAMA Cardiol"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120304124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527120304124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:51:09Z","timestamp":1761547869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527120304124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1547527120304124"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.04.036","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of subcutaneous implantable cardioverter-defibrillator in dialysis patients: Results from the S-ICD post-approval study","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2020.04.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Heart Rhythm Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}